Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Human Genome Sciences Rejects GlaxoSmithKline's $2.6 Billion Offer

May 21, 2012

Human Genome Sciences rejects GlaxoSmithKline offer to acquire the company and issues a poison pill to prevent a takeover.

Ongoing Challenges in Continuous Manufacturing

Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.
May 16, 2012

Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.

Achieving Containment in High-Potency Manufacturing

The growing use of high-potency APIs is leading to changes in how the pharmaceutical industry looks at containment.
Apr 18, 2012

The growing use of high-potency APIs is leading to changes in how the pharmaceutical industry looks at containment.

Scale-up Challenges in Hot-Melt Extrusion

Critical issues that should be considered when scaling up a hot-melt extrusion process.
Apr 2, 2012

Critical issues that should be considered when scaling up a hot-melt extrusion process.

Modular Factory Concept Gains Traction

Modular factory concepts, which take flexible manufacturing to the next level, are beginning to take hold in the biopharmaceutical industry.
Mar 21, 2012

Modular factory concepts, which take flexible manufacturing to the next level, are beginning to take hold in the biopharmaceutical industry.

FDA Issues Guidance for Industry Direct-to-Consumer Television Advertisements

Mar 15, 2012

On Mar. 12, 2012, FDA released a draft guidance document for industry direct-to-consumer television advertisements that describes FDA's plans for implementing predissemination review.

Mid-Size Extruders Enable Scale-Up of Hot-Melt Extrusion

With the increasing use of hot-melt extrusion, extruder manufacturers have developed mid-size twin-screw extruders that facilitate process development and scale-up to commercial processes.
Feb 15, 2012

With the increasing use of hot-melt extrusion, extruder manufacturers have developed mid-size twin-screw extruders that facilitate process development and scale-up to commercial processes.

Pfizer's 2011 Financial Information Shows Overall Increase

Feb 2, 2012

Pfizer announced a decrease in fourth-quarter revenues, but a slight increase in full-year 2011 revenues in its financial report on Jan. 31, 2012.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here